Naughty Flicks

Skip NavigationMarketsBusinessInvestingTechPolitics & PolicyVideoWatchlistInvesting ClubPROLivestreamMenuHere are Wednesday’s biggest calls on Wall Street: UBS upgrades Invesco to buy from neutral UBS said the stock is undervalued. “We assume coverage of Invesco (IVZ) with a Buy rating and $41 price target. We believe the market underestimates the durability of Invesco’s growth profile.” Raymond James initiates M & T Bank as outperform The firm called the bank “high performing.” “We are initiating coverage on MTB with an Outperform rating and $250 target price.” Morgan Stanley upgrades Nexa Resources to overweight from equal weight Morgan Stanley said the metals and mining company has a compelling valuation. “Upgrade NEXA t o OW as recent underperformance seems overdone and new estimates point to shares trading well below 5yr average multiples w/ strong FCF yields.” KeyBanc upgrades Corteva to overweight from equal weight Key said the stock is in “deep value territory.” “We are upgradin g CTVA t o Overweight from SW with a $17 PT & updating estimates following the spin-off of VYLR.” Jefferies upgrades Ambiq Micro to buy from neutral Jefferies said semis company has “high potential.” “We initiate AMBQ with a Buy/$90 PT.” Citi upgrades Flutter to buy from neutral Citi said buy the weakness. “We upgrade Flutter to Buy (from Neutral) with a $91 TP and sit materially above VA cons on 3Q26e US Adj. EBITDA.” Oppenheimer initiates Brown & Brown as outperform The firm said shares of the insurance broker are compelling. “Initiating coverage on BRO w ith an Outperform rating and a $73 price target, representing about 20% upside potential from current levels.” JPMorgan upgrades Afya to overweight from neutral JPMorgan said the LatAm medical education company is attractive. “We are Overweight on Afya.. .” HSBC upgrades Allstate to buy from hold HSBC said the company has plenty of upside. “We upgrade our rating on ALL to Buy from Hold.” KBW upgrades Moelis & Co to outperform from market perform KBW said it sees “improving deal activity.” “To this end, we are upgrading MC to Outperform and downgrading PJT to Market Perform given diverging public pipeline and completion data and our expectation for MC to capitalize on improving deal activity in the sub-$10B deal range.” Morgan Stanley reiterates SpaceX as overweight Morgan Stanley said SpaceX is going to create “millions” of jobs. “The next chapter of the SpaceX story is its role in converting energy (e) into intelligence (i) through physical robots (r) manufactured on/near shore.” TD Cowen upgrades Marvell to buy from hold The firm upgraded the stock following its investor day. “Upgrading Marvell as the fundamental growth drivers for the company have, in our view, now fully shifted to the company’s strong connectivity franchise and more importantly the concentration (and margin) risk associated with custom XPU programs has been largely derisked.” Read more. Citi upgrades XPO to buy from neutral Citi said buy the dip. “…and we follow this with an upgrade of XPO to Buy from Neutral given its decline from the $230 range to current $183/sh. Notably, XPO sounded particularly upbeat into 3Q earnings, with opportunities for share gains and pricing strength.” UBS reiterates Tesla as neutral UBS raised its price target to $391 per share from $385 ahead of earnings. “Stock reactions the last few quarters have not been driven significantly by NT fundamentals with continued focus on TSLA’s long term physical ventures. Investor belief in these long-term value drivers is likely to create a high floor for the stock in the quarters ahead, however.” Barclays initiates Abbott Labs as overweight Barclays said Abbott has a large pipeline. ” Abbott is one of the largest diversified healthcare companies in the world, with nearly $50B in revenue.’ Seaport initiates Solstice Advanced Materials as buy The firm said the specialty materials company is firing on all cylinders. “We are initiating coverage of SOLS, a leading supplier of high-performance specialty materials with exposure to a range of attractive end markets, with a Buy rating and $80 price target.” Yorkville Ives initiates Nvidia as outperform The firm said it likes the company’s competitive advantage. “We are initiating coverage of NVIDIA (NVDA) with an OUTPERFORM rating and $300 PT.” Yorkville Ives initiates Apple as outperform Yorkville Ives said Apple is entering a “new phase of its ecosystem.” “We are initiating coverage on AAPL with an OUTPERFORM rating and $400 price target.” Morgan Stanley upgrades Gold Fields to overweight from equal weight Morgan Stanley said buy the dip. “We upgrade Gold Fields to Overweight post underperformance through 2026.” Evercore ISI upgrades NetApp to outperform from in line Evercore said growth “appears conservative.” “We are upgrading NTAP to Outperform from In Line and raising our target to $300.” Read more. JPMorgan initiates Savara as overweight JPMorgan said the biotech company has plenty of upside. “We are initiating coverage of Savara Inc (SVRA) with an Overweight rating and a Dec 2027 price target of $12.” Oppenheimer initiates SailPoint as outperform Oppenheimer said the company is a “leader.” “We’re initiating on SailPoint Technologies with an Outperform rating and a $30 price target. SailPoint is a leader in identity governance security across human, machine, and AI agent identities.” Cantor Fitzgerald upgrades Humana to overweight from neutral Cantor said the stock is cheap. “We are upgrading HUM to Overweight from Neutral, raising our price target to $460 from $300, increasing ’27 EPS to $17.96 vs. prior $15.86, and ’28 EPS to $28.27 vs. prior $25.38.” DA Davidson reiterates Micron as buy DA raised its price target on Micron following a series of investor meetings. “We attended investor meetings with Samir Patodia, Sr. Director of IR, and Jeff Grattan, Director of IR, which allowed us to get an updated sense for investor sentiment and questions. … .We reiterate the Buy rating and increase our price target to $3,000 from $2,100, a 19x market multiple on our FY27 EPS estimate.” Northcoast upgrades nLight to buy from neutral The firm said investors should buy the weakness. “We are raising our rating on shares o f nLIGHT from NEUTRAL to BUY with a $75 price target as we believe the shares’ recent pullback in response to supply chain challenges is providing investors with a good opportunity to buy the shares.” Deutsche Bank initiates AptarGroup as buy Deutsche said it sees “margin expansion opportunities” for the biopharma company. “Initiating coverage on ATR with a Buy rating and a $150 price target.”Read More